Signum Biosciences
0 followers
‌
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
Industries
+1
Headquarters
Employees
Links
Org chart
Maxwell Stock
CEO & Founder
Maxwell Stock
Collapse
Lisa Johnson
Senior Vice President Of Global Sales & Corporate Development
Masanori (Markie) Tamura
Vice President of Product Development
Michael J. Losch
Chief Financial Officer
Jose Fernandez
Director of Research & Development
José R. Fernández
Director of Research and Development
